Epidermal growth factor receptor is highly expressed in a variety of solid tumors, including NSCLC, and its activation has been shown to promote processes involved in tumor cell proliferation, angiogenesis, invasion, metastasis, and inhibition of apoptosis (Vansteenkiste, 2004). The gene discussed is EGFR; the disease is neoplasm.